ArticleFrontiers in oncology2026

Correction: Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.

Minhan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.